Accolade Market Cap

Gilead Sciences has a market cap or net worth of 106.29 billion as of August 1, 2025. Its market cap has increased by 51.37% in one year.

Market Cap

106.29B

Enterprise Value

118.48B

Revenue

22.24B

Ranking

n/a

PE Ratio

23.02

Stock Price

$112.87

Market Cap Chart

Since January 22, 1992, Gilead Sciences's market cap has increased from 138.73M to 106.29B, an increase of 76,514.46%. That is a compound annual growth rate of 21.89%.

Market Cap History

Date	Market Cap	% Change
Aug 1, 2025	106.29B	15.59%
Dec 31, 2024	91.95B	16.03%
Dec 29, 2023	79.25B	-11.32%
Dec 30, 2022	89.37B	32.86%
Dec 31, 2021	67.26B	25.75%
Dec 31, 2020	53.49B	-13.83%
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AstraZeneca	175.60B
Shell	159.31B
HSBC Holdings	159.21B
Unilever	109.82B
Rolls-Royce Holdings	89.59B
British American Tobacco p.l.c.	88.30B
Rio Tinto Group	76.37B
RELX PLC	71.14B

Market Cap Rankings